From Trials to Trials: Blinding, Medicine, and Honest Adjudication

Blinding as a Solution to Bias: Strengthening Biomedical Science, Forensic Science, and Law

Volumn , Issue , 2016, Pages 45-58

  Podolsky, Scott H ^a   Jones, David S ^a,b   Kaptchuk, Ted J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD UNIVERSITY   (United States)

Author keywords

Bias; Blinding; Clinical trials; Expert witness; Objectivity; Patients; Therapeutics

Indexed keywords

EID: 84973298631     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-802460-7.00003-6     Document Type: Chapter

References (86)

1. J.B. Amberson, B.T. McMahon and M. Pinner (1931) A clinical trial of sanocrysin in pulmonary tuberculosis. American Review of Tuberculosis 24 401-435.
2. Anon (1874) Expert testimony in judicial proceedings. Albany Law Journal 9 122.
3. Anon (1909) The personal equation in medicine. Journal of the American Medical Association 53 1825-1826.
4. Anon (1947) The “personal equation” in the interpretation of a chest roentgenogram. Journal of the American Medical Association 133 399-400.
5. S. Babitsky and J.J. Mangraviti (2005) How to Become a Dangerous Expert Witness: Advanced Techniques and Strategies. Falmouth, MA: SEAK, Inc.
6. J. Bacon (1858) Introductory address. Boston Medical and Surgical Journal 59 300-302.
7. H.K. Beecher (1955) The powerful placebo. Journal of the American Medical Association 159 1602-1605.
8. H.K. Beecher (1961) Surgery as placebo: a quantitative study of bias. Journal of the American Medical Association 176 1102-1107.
9. F. Berlin (1998) Unpaid expert witnesses. New England Journal of Medicine 338 1233. (Letter to the Editor)
10. J. Bigelow (1812) Observations and experiments on the treatment of injuries occasioned by fire and heated injuries. New England Journal of Medicine, Surgery, and Collateral Branches of Science 1 52-63.
11. C.C. Birkelo, W.E. Chamberlain, W.E. Phelps, P.E. Schools and D. Zacks (1947) Tuberculosis case finding: a comparison of the effectiveness of various roentgenographic and photofluorographic methods. Journal of the American Medical Association 133 359-366.
12. W.E. Boden, R.A. O’Rourke, K.K. Teo, P.M. Hartigan, D.J. Maron, W.J. Kostuk, M. Knudtson, M. Dada, P. Casperson, C.L. Harris, B.R. Chaitman, L. Shaw, G. Gosselin, S. Nawaz, L.M. Title, G. Gau, A.S. Blaustein, D.C. Booth, E.R. Bates, J.A. Spertus, D.S. Berman, J. Mancini, W.S. Weintraub and COURAGE Trial Research Group (2007) Optimal medical therapy with or without PCI for stable coronary disease. New England Journal of Medicine 356 1503-1516.
13. V.Y. Bowditch (1894) Three years’ experience with sanitarium treatment of pulmonary diseases near Boston. Boston Medical and Surgical Journal 131 49-51.
14. V.Y. Bowditch (1900) The Massachusetts State Hospital for consumptives at Rutland; its purpose and the work accomplished during the first year. Boston Medical and Surgical Journal 142 127-130.
15. C.É. Brown-Séquard (1889) Note on the effects produced on man by subcutaneous injections of a liquid obtained from the testicles of animals. Lancet 2 105-107.
16. R. Buchbinder, R.H. Osborne, P.R. Ebeling, J.D. Wark, P. Mitchell, C. Wriedt, S. Graves, M.P. Staples and B. Murphy (2009) A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures. New England Journal of Medicine 361 557-568.
17. J. Canales (2007) Sensational differences: the case of the transit of Venus. Cahiers François Viète 11–12 15-40.
18. I. Chalmers (2005) Statistical theory was not the reason that randomisation was used in the British Medical Research Council’s clinical trial of streptomycin for pulmonary tuberculosis. G. Jorland, A. Opinel, G. Weisz (Eds) Body Counts: Medical Quantification in Historical and Sociological Perspectives Montreal: McGill-Queens University Press 309-334.
19. I. Chalmers (2011) Why the 1948 MRC trial of streptomycin used treatment allocation based on random numbers. Journal of the Royal Society of Medicine 104 383-386. www.jameslindlibrary.org Also in
20. I. Chalmers, E. Dukan, S. Podolsky and G.D. Smith (2012) The advent of fair treatment allocation schedules in clinical trials during the 19th and early 20th centuries. Journal of the Royal Society of Medicine 105 221-227. www.jameslindlibrary.org Also in
21. T.C. Chalmers, H. Smith, A. Ambroz, D. Ritman and B.J. Schroeder (1978) In defense of the VA randomized control trial of coronary artery surgery. Clinical Research 26 233-235.
22. F.J. Cotton (1899) The present status of the antistreptococcic serum. Boston Medical and Surgical Journal 140 105-108.
23. W.J. Curran (1965) Tracy’s the Doctor as a Witness. second ed. Philadelphia, PA: W.B. Saunders
24. R. Darnton (1968) Mesmerism and the End of the Enlightenment in France. Cambridge, MA: Harvard University Press
25. L. Daston and P. Gallison (2007) Objectivity. New York, NY: Zone Books
26. M.E. Dean (2006) “An innocent deception”: placebo controls in the St Petersburg homeopathy trial, 1829–1830. Journal of the Royal Society of Medicine 99 375-376. www.jameslindlibrary.org Also in
27. G.A. Diamond and S. Kaul (2007) COURAGE under fire. Journal of the American College of Cardiology 50 1604-1609.
28. H.S. Diehl (1933) Medicinal treatment of the common cold. Journal of the American Medical Association 101 2042-2049.
29. F.W. Draper (1880) Medical expert testimony. Boston Medical and Surgical Journal 103 442-446.
30. C.C. Edwards (1970) Hearing regulations and regulations describing scientific content of adequate and well-controlled clinical investigations. Federal Register 35 7250-7253.
31. A.R. Feinstein (1978) The scientific and clinical tribulations of randomized clinical trials. Clinical Research 26 241-244.
32. M. Finland (1941) Controlling clinical therapeutic experiments with specific serums – with particular reference to antipneumococcus serums. New England Journal of Medicine 225 495-506.
33. D.G. Finniss, T.J. Kaptchuk, F. Miller and F. Benedetti (2010) Biological, clinical, and ethical advances of placebo effects. Lancet 375 686-695.
34. B. Franklin and Other commissioners (1785) Report of Dr. Benjamin Franklin and Other Commissioners, Charged by the King of France, with the Examination of Animal Magnetism, as Now Practiced in Paris. London: J. Johnson (W. Goodman, Trans.)
35. T.B. Freeman, D.E. Vawter, P.E. Leaverton, J.H. Godbold, R.A. Hauser, C.G. Goetz and C.W. Olanow (1999) Use of placebo surgery in controlled trials of a cellular-based therapy for Parkinson’s disease. New England Journal of Medicine 341 988-992.
36. J. Freeman (1910) Vaccine therapy. Proceedings of the Royal Society of Medicine 3 97-101.
37. J.M. Gabriel (2014) The testing of sanocrysin: science, profit, and innovation in clinical trial design, 1926–1931. Journal of the History of Medicine and Allied Sciences 69 604-632.
38. H. Gold (1954) How to evaluate a new drug. American Journal of Medicine 11 722-727.
39. H. Gold, N.T. Kwit and H. Otto (1937) The xanthines (theobromine and aminophylline) in the treatment of cardiac pain. Journal of the American Medical Association 108 2173-2179.
40. J.A. Greene, F. Condrau and E. Watkins (2016) Therapeutic Revolutions: Pharmaceuticals and Social Change in the Twentieth Century. Chicago, IL: University of Chicago Press
41. M. Greenwood (1948) Simple statistics of cancer. Lancet 252 781-782.
42. T. Greiner, H. Gold, M. Cattell, J. Travell, H. Bakst, S.H. Rinzler, Z.H. Benjamin, L.J. Warshaw, A. Bobb, N.T. Kwit, W. Modell, H.H. Rothendler, C.R. Messeloff and M.L. Kramer (1950) A method for the evaluation of the effects of drugs on cardiac pain in patients with angina of effort. American Journal of Medicine 9 143-155.
43. J.S. Haller (2005) The History of American Homeopathy: the Academic Years, 1820–1935. New York, NY: Pharmaceutical Products Press
44. J. Haygarth (1801) Of the Imagination, as a Cause and as a Cure of Disorders of the Body: Exemplified by Fictitious Tractors and Epidemical Convulsions. Bath: R. Cruttwell
45. E.M. Hediger and H. Gold (1935) U.S.P. ether from large drums and ether from small cans labeled for “anesthesia”. Journal of the American Medical Association 104 2244-2248.
46. S.S. Herrick (1895) Reform in medical expert testimony. Journal of the American Medical Association 25 444-445.
47. A.W. Hewlett (1913) Clinical effects of “natural” and “synthetic” sodium salicylate. Journal of the American Medical Association 61 319-321.
48. O.W. Holmes (1842) Homoeopathy and its kindred delusions. O. Holmes (Eds) Medical Essays, 1842–1882 Boston, MA: Houghton, Mifflin and Company
49. L.E. Holt, W.P. Northrup, J. O’Dwyer and S.S. Adams (1896) The report of the American Pediatric Society’s collective investigation into the use of antitoxin in the treatment of diphtheria in private practice. Transactions of the American Pediatric Society 8 21-45.
50. J.C. Irish (1899) Medical expert testimony. Boston Medical and Surgical Journal 140 299-301.
51. T.J. Kaptchuk, C.E. Kerr and A. Zanger (2009) Placebo controls, exorcisms, and the devil. Lancet 374 1234-1235.
52. T.J. Kaptchuk (1998) Powerful placebo: the dark side of the randomised controlled trial. Lancet 351 1722-1725.
53. T.J. Kaptchuk (1998) Intentional ignorance: a history of blind assessment and placebo controls in medicine. Bulletin of the History of Medicine 72 389-433.
54. T.J. Kaptchuk (2004) Early Use of Blind Assessment in a Homeopathic Scientific Experiment. www.jameslindlibrary.org Also in
55. M. Kaufman (1988) Homeopathy in America: the rise and fall and persistence of a medical heresy. N. Gevitz (Eds) Other Healers: Unorthodox Medicine in America Baltimore, MD: Johns Hopkins University Press 99-123.
56. D.J. Kereiakes, P.S. Teirstein, I.J. Sarembock, D.R. Holmes, M.W. Krucoff, W.W. O’Neill, R. Waksman, D.O. Williams, J.J. Popma, M. Buchbinder, R. Mehran, I.T. Meredith, J.W. Moses and G.W. Stone (2007) The truth and consequences of the COURAGE Trial. Journal of the American College of Cardiology 50 1598-1603.
57. C.H. Knight (1905) Notes on the treatment of hay fever and asthma. Boston Medical and Surgical Journal 153 85-86.
58. E.F. Lewison and R.G. Chambers (1952) The sex hormones in advanced breast cancer. New England Journal of Medicine 246 1-8.
59. H.A. Liebenson (1961) You, the Medical Witness. Chicago, IL: Year Book Medical Publishers
60. H.M. Marks (2006) “Until the sun of science … the true Apollo of medicine has risen”: collective investigation in Britain and America, 1880–1910. Medical History 50 147-166.
61. Medical Research Council (1948) Streptomycin treatment of pulmonary tuberculosis: a Medical Research Council investigation. British Medical Journal 2 769-782.
62. J. Mohr (1993) Doctors and the Law: Medical Jurisprudence in Nineteenth-Century America. New York, NY: Oxford University Press
63. J.B. Moseley, K.O. O’Malley, N.J. Petersen, T.J. Menke, B. Brody, D.H. Kaykendall, J.C. Hollingsworth, C.M. Ashton and N.P. Wray (2002) A controlled trial of arthroscopic surgery for osteoarthritis of the knee. New England Journal of Medicine 347 81-88.
64. M.L. Murphy, H.N. Hultgren, K. Detre, J. Thomsen, T. Takaro and Participants of the Veterans Administration Cooperative Study (1977) Treatment of chronic stable angina: a preliminary report of survival data of the randomized Veterans Administration cooperative study. New England Journal of Medicine 297 621-627.
65. F.A. Pemberton (1925) Progress in gynaecology. Boston Medical and Surgical Journal 192 609-617.
66. B. Phibbs (1997) Unpaid expert witnesses. New England Journal of Medicine 337 1477-1478. (Letter to the Editor)
67. E.D. Plass (1916) Post-partum care of the perineum. Bulletin of the Johns Hopkins Hospital 27 107-109.
68. S.H. Podolsky (2006) Pneumonia before Antibiotics: Therapeutic Evolution and Evaluation in Twentieth-Century America. Baltimore, MD: Johns Hopkins University Press
69. S.H. Podolsky (2007) Quintessential Beecher: surgery as placebo, a quantitative study of bias. International Anesthesiology Clinics 45 47-63.
70. S. Potter and E.F. Storke (1880) Final report of the Milwaukee test of the thirtieth dilution. Homeopathic Times: A Monthly Journal of Medicine, Surgery, and the Collateral Sciences 7 280-281.
71. W.L. Proudfit (1978) Criticisms of the VA randomized study of coronary bypass surgery. Clinical Research 26 236-240.
72. R.F. Redberg (2014) Sham controls in medical trials. New England Journal of Medicine 371 892-893.
73. C.E. Rosenberg (1979) The therapeutic revolution: medicine, meaning, and social change in nineteenth-century America. M.J. Vogel, C.E. Rosenberg (Eds) The Therapeutic Revolution: Essays in the Social History of American Medicine Philadelphia, PA: University of Pennsylvania Press 3-25.
74. S. Schaffer (1988) Astronomers mark time: discipline and the personal equation. Science in Context 2 115-145.
75. K.F. Schulz, I. Chalmers and D.G. Altman (2002) The landscape and lexicon of blinding in randomized trials. Annals of Internal Medicine 136 254-259.
76. K.F. Schulz and D.A. Grimes (2002) Blinding in randomised trials: hiding who got what. Lancet 359 696-700.
77. A.K. Shapiro and E. Shapiro (1997) The Powerful Placebo: from Ancient Priest to Modern Physician. Baltimore, MD: Johns Hopkins University Press
78. M. Stolberg (2006) Inventing the randomized double-blind trial: the Nürnberg salt test of 1835. Journal of the Royal Society of Medicine 99 642-643. www.jameslindlibrary.org Also in
79. H.R. Storer (1863) Studies of abortion. Boston Medical and Surgical Journal 68 15-20.
80. U. Tröhler (2011) Adolf Bingel’s blinded, controlled comparison of different anti-diphtheric sera in 1918. Journal of the Royal Society of Medicine 104 302-305. www.jameslindlibrary.org Also in
81. A. Trousseau and H. Gourard (1834) Repertoire clinique: Experiences homoeopathiques tentees a l’Hotel-Dieu de Paris. Journal des Connaissances Medico-Chirurgicales 8 238-241.
82. J.P. Vandenbroucke (2013) Adolphe Vorderman’s 1897 study on beriberi: an example of scrupulous efforts to avoid bias. Journal of the Royal Society of Medicine 106 108-111. www.jameslindlibrary.org Also in
83. A.I. Von Sholly, J. Blum and L. Smith (1917) The therapeutic value of pertussis vaccine in whooping cough. Journal of the American Medical Association 68 1451-1456.
84. J.H. Warner (1986) The Therapeutic Perspective: Medical Practice, Knowledge, and Identity in America, 1820–1885. Cambridge, MA: Harvard University Press
85. J.H. Warner (1991) Ideals of science and their discontents in late nineteenth-century American medicine. Isis 82 454-478.
86. J.C. Wilson (1883) Observations on the management of enteric fever according to a plan based upon the so-called specific treatment. Boston Medical and Surgical Journal 108 99-102.